Compositions including iron
OwnerJonathan Bortz, Mitchell Kirschner +1inventors
InventorsJonathan Bortz, Mitchell Kirschner, David Hermelin
Life of this patent
Estimating the term…
Abstract
Nutritional or dietary supplement compositions that promote and/or maintain dietary iron absorption through administration of iron with an organic acid and optionally similar iron absorption promoters are provided. Also provided are methods of nutritional or dietary supplementation using one or more compositions that promote and/or maintain health through the prevention, stabilization, reversal and/or treatment of disorders associated with iron deficiency.
Claims51
A composition comprising:
- about 10 mg to about 500 mg of one or more forms of iron;
- and
- about 5 mg to about 500 mg of one or more forms of an organic acid, for administration to prevent, stabilize, reverse or treat disorders related to iron deficiency in a human or other animal.
A composition comprising:
- about 10 mg to about 500 mg of one or more forms of iron;
- about 5 mg to about 500 mg of one or more forms of an organic acid;
- and
- about 5 mg to about 500 mg of one or more iron absorption promoters, to prevent, stabilize, reverse or treat disorders related to iron deficiency in a human or other animal.
A composition comprising:
- about 10 mg to about 500 mg of one or more forms of iron;
- about 5 mg to about 500 mg of one or more forms of an organic acid;
- and
- about 5 mg to about 500 mg of one or more forms of ascorbic acid, to prevent, stabilize, reverse or treat disorders related to iron deficiency in a human or other animal.
A composition comprising:
- about 10 mg to about 500 mg of one or more forms of iron;
- and
- about 5 mg to about 500 mg of one or more forms of an organic acid, to prevent, stabilize, reverse or treat iron deficiency anemia in a human or other animal.
A composition comprising:
- about 10 mg to about 500 mg of one or more forms of iron;
- about 5 mg to about 500 mg of one or more forms of an organic acid;
- and
- about 5 mg to about 500 mg of one or more iron absorption promoters, to prevent, stabilize, reverse or treat iron deficiency anemia in a human or other animal.
A composition comprising:
- about 10 mg to about 500 mg of one or more forms of iron;
- about 5 mg to about 500 mg of one or more forms of an organic acid;
- and
- about 5 mg to about 500 mg of one or more forms of ascorbic acid, to prevent, stabilize, reverse or treat iron deficiency anemia in a human or other animal.
A composition comprising:
- about 10 mg to about 500 mg of one or more forms of iron;
- and
- about 5 mg to about 500 mg of one or more forms of an organic acid, effective using cyclical administration in the prevention, stabilization, reversal or treatment of disorders associated with iron deficiency in a human or other animal.
A composition comprising:
- about 10 mg to about 500 mg of one or more forms of iron;
- and
- about 5 mg to about 500 mg of one or more forms of an organic acid, effective using cyclical administration in the prevention, stabilization, reversal or treatment of iron deficiency anemia in a human or other animal.
A composition comprising:
- about 100 mg of bis-glycine chelated iron;
- about 50 mg of ferrous fumarate iron;
- about 150 mg of succinic acid;
- about 60 mg of an iron absorption promoter;
- about 1 mg of folic acid;
- and
- about 10 mcg of Vitamin B12.
A composition comprising:
- about 10 mg to about 500 mg of one or more forms of iron;
- and
- about 5 mg to about 500 mg of one or more forms of succinic acid, to prevent, stabilize, reverse or treat disorders related to iron deficiency in a human or other animal prior to or during oncology related therapy, pre-dialysis phase of chronic renal failure or repeated blood donations.
A method of using a composition comprising:
- administering to a human or other animal about 10 mg to about 500 mg of one or more forms of iron;
- and about 5 mg to about 500 mg of one or more forms of an organic acid, to prevent, stabilize, reverse or treat disorders related to iron deficiency in said human or other animal prior to or during oncology related therapy, pre-dialysis phase of chronic renal failure or repeated blood donations.
A composition comprising:
- about 10 mg to about 500 mg of one or more forms of iron orally administered using cyclical administration to optimize absorption for prevention, stabilization, reversal or treatment of disorders associated with iron deficiency.
Dependencies are inferred from the claim text.